BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29653190)

  • 1. Evaluation of whole genome sequencing and software tools for drug susceptibility testing of Mycobacterium tuberculosis.
    van Beek J; Haanperä M; Smit PW; Mentula S; Soini H
    Clin Microbiol Infect; 2019 Jan; 25(1):82-86. PubMed ID: 29653190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis: can we use them for clinical decision guidance?
    Macedo R; Nunes A; Portugal I; Duarte S; Vieira L; Gomes JP
    Tuberculosis (Edinb); 2018 May; 110():44-51. PubMed ID: 29779772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis.
    Iwamoto T; Murase Y; Yoshida S; Aono A; Kuroda M; Sekizuka T; Yamashita A; Kato K; Takii T; Arikawa K; Kato S; Mitarai S
    PLoS One; 2019; 14(2):e0212798. PubMed ID: 30817803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
    Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
    Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnaround time of whole genome sequencing for mycobacterial identification and drug susceptibility testing in routine practice.
    Olaru ID; Patel H; Kranzer K; Perera N
    Clin Microbiol Infect; 2018 Jun; 24(6):659.e5-659.e7. PubMed ID: 29030167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of drug susceptibility profile of Mycobacterium tuberculosis Lineage 1 from Brazil based on whole genome sequencing and phenotypic methods.
    Guimarães AEDS; Sharma A; Furlaneto IP; Rutaihwa L; Cardoso JF; da Conceição ML; Spinassé LB; Machado E; Lopes ML; Duarte RS; Gagneux S; Suffys PN; Lima KVB; Conceição EC
    Mem Inst Oswaldo Cruz; 2021; 115():e200520. PubMed ID: 33533871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing.
    Jajou R; van der Laan T; de Zwaan R; Kamst M; Mulder A; de Neeling A; Anthony R; van Soolingen D
    J Antimicrob Chemother; 2019 Sep; 74(9):2605-2616. PubMed ID: 31119271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Five User-Friendly Whole Genome Sequencing Software for
    Kim N; Seok KH; Shin S; Kim B; Park H; Roh EY; Yoon JH; Shin S
    J Korean Med Sci; 2022 Nov; 37(46):e328. PubMed ID: 36631026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.
    Chaidir L; Ruesen C; Dutilh BE; Ganiem AR; Andryani A; Apriani L; Huynen MA; Ruslami R; Hill PC; van Crevel R; Alisjahbana B
    J Glob Antimicrob Resist; 2019 Mar; 16():170-177. PubMed ID: 30172045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome sequencing analysis of multidrug-resistant
    Tania T; Sudarmono P; Kusumawati RL; Rukmana A; Pratama WA; Regmi SM; Kaewprasert O; Chaiprasert A; Chongsuvivatwong V; Faksri K
    J Med Microbiol; 2020 Jul; 69(7):1013-1019. PubMed ID: 32579102
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing.
    Doyle RM; Burgess C; Williams R; Gorton R; Booth H; Brown J; Bryant JM; Chan J; Creer D; Holdstock J; Kunst H; Lozewicz S; Platt G; Romero EY; Speight G; Tiberi S; Abubakar I; Lipman M; McHugh TD; Breuer J
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29848567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of AAICare®-TB sequence analysis tool for accurate diagnosis of drug-resistant tuberculosis: A comparative study with TB-Profiler and Mykrobe.
    Singhal R; Hingane S; Bhalla M; Sharma A; Ferdosh S; Tiwari A; Jayaswal P; Yadav RN; Arora J; Dewan RK; Sharma S
    Tuberculosis (Edinb); 2024 Jul; 147():102515. PubMed ID: 38744006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs.
    Phelan JE; O'Sullivan DM; Machado D; Ramos J; Oppong YEA; Campino S; O'Grady J; McNerney R; Hibberd ML; Viveiros M; Huggett JF; Clark TG
    Genome Med; 2019 Jun; 11(1):41. PubMed ID: 31234910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data.
    Sharma MK; Stobart M; Akochy PM; Adam H; Janella D; Rabb M; Alawa M; Sekirov I; Tyrrell GJ; Soualhine H
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic prediction of tuberculosis drug-resistance: benchmarking existing databases and prediction algorithms.
    Ngo TM; Teo YY
    BMC Bioinformatics; 2019 Feb; 20(1):68. PubMed ID: 30736750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis.
    Ardito F; Posteraro B; Sanguinetti M; Zanetti S; Fadda G
    J Clin Microbiol; 2001 Dec; 39(12):4440-4. PubMed ID: 11724858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis.
    Bemer P; Palicova F; Rüsch-Gerdes S; Drugeon HB; Pfyffer GE
    J Clin Microbiol; 2002 Jan; 40(1):150-4. PubMed ID: 11773109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools.
    Schleusener V; Köser CU; Beckert P; Niemann S; Feuerriegel S
    Sci Rep; 2017 Apr; 7():46327. PubMed ID: 28425484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.